Keyphrases
Clinical Trials
100%
Randomized Controlled Trial
100%
Meta-analysis
100%
Systematic Meta-analysis
100%
Immunosuppression
100%
Membranous Nephropathy
100%
Alkylating Agents
20%
All-cause Mortality
20%
Complete Remission
20%
Nephrotic Syndrome
20%
Partial Remission
20%
Idiopathic Membranous Nephropathy
20%
Confidence Interval
10%
Adverse Events
10%
Subgroup Analysis
10%
Cochrane Library
10%
Embase
10%
Chlorambucil
10%
Hospitalization
10%
Cyclophosphamide
10%
Corticosteroids
10%
Mycophenolate Mofetil
10%
Risk Ratio
10%
Cyclosporine
10%
Proteinuria
10%
Meta-analysis of Randomized Controlled Trials
10%
Tacrolimus
10%
Adrenocorticotropic Hormone
10%
PubMed
10%
Clinical Trial Registry
10%
Medicine and Dentistry
Systematic Review
100%
Clinical Trial
100%
Immunosuppressive Treatment
100%
Randomized Controlled Trial
100%
Meta-Analysis
100%
Membranous Glomerulonephritis
100%
All Cause Mortality
18%
End Stage Renal Disease
18%
Nephrotic Syndrome
18%
Alkylating Antineoplastic Agent
18%
Subgroup Analysis
9%
Cyclophosphamide
9%
Proteinuria
9%
Adverse Event
9%
Mycophenolate Mofetil
9%
Tacrolimus
9%
Cyclosporine
9%
Corticotropin
9%
Chlorambucil
9%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Randomized Controlled Trial
100%
Membranous Glomerulonephritis
100%
Alkylating Agent
18%
All Cause Mortality
18%
Remission
18%
End Stage Renal Disease
18%
Nephrotic Syndrome
18%
Adverse Event
9%
Chlorambucil
9%
Cyclophosphamide
9%
Mycophenolate Mofetil
9%
Proteinuria
9%
Ciclosporin
9%
Corticotropin
9%
Tacrolimus
9%
Immunology and Microbiology
Immunosuppression
100%
Membranous Glomerulonephritis
100%
All Cause Mortality
40%
Cyclophosphamide
20%
Ciclosporin
20%
Tacrolimus
20%
Cochrane Library
20%
Mycophenolate Mofetil
20%